Benjamin Viglianti
Clinical trials sponsored by Benjamin Viglianti, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New imaging agent could shed light on Cholesterol's role in disease Results expected Dec 2026 (estimated)
- New imaging tracer could shed light on adrenal cholesterol Results expected Dec 2026 (estimated)
-
New imaging agent could shed light on Cholesterol's role in disease
Knowledge-focused Recruiting nowThis early-phase study is testing a new radioactive tracer called [18F]FNP-59 to see if it can safely and clearly image cholesterol in the adrenal glands using PET scans. Six healthy volunteers will receive a tiny, non-therapeutic dose of the tracer. The goal is to improve imagin…
Early phase 1 • Sponsor: Benjamin Viglianti • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New imaging tracer could shed light on adrenal cholesterol
Knowledge-focused Recruiting nowThis study tests a special radioactive tracer called [18F]FNP-59 to see if it can safely and clearly show cholesterol activity in the adrenal gland using PET scans. About 24 people will take part, including healthy volunteers and those with known adrenal problems. The goal is to …
Early phase 1 • Sponsor: Benjamin Viglianti • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC